Erasca, Inc.
Clinical trials sponsored by Erasca, Inc., explained in plain language.
-
First patients to test new oral cancer drug targeting specific mutations
Disease control Recruiting nowThis is the first study in humans testing a new oral cancer drug called ERAS-0015. Researchers want to find the safest dose and see if it helps control advanced solid tumors that have spread and have specific genetic changes. The drug will be tested alone and combined with other …
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Apr 04, 2026 06:35 UTC
-
First patients to try new pill targeting common cancer mutation
Disease control Recruiting nowThis is the first study in people to test a new oral drug called ERAS-4001. It aims to find a safe dose and see how the body handles the drug in patients with advanced solid tumors that have specific KRAS mutations. The drug will be tested alone and in combination with other canc…
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC